在阿尔茨海默氏症的DNA甲基化
Luke Weymouth1, Adam R Smith1, Katie Lunnon2
1Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.
Current topics in behavioral neurosciences
|October 25, 2024
概括
DNA甲基化,一种表观遗传变化,是阿尔茨海默病研究的关键. 研究表明,它可以使基因沉默,并可能将环境因素与疾病联系起来,为阿尔茨海默病的机制提供了新的见解.
科学领域:
- 神经科学是一个神经科学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 基因组学就是基因组学.
背景情况:
- 基因甲基化是阿尔茨海默病 (AD) 中研究最多的表观遗传修饰.
- 它涉及将甲基组添加到细胞蛋白中,通常会使基因表达沉默.
- 像DNA甲基化这样的表观遗传机制可能会在AD中调解基因环境相互作用.
研究的目的:
- 对阿尔茨海默病的表观遗传学研究进行全面审查.
- 专注于DNA甲基化在人类大脑组织和细胞类型中的作用.
- 突出AD中关键的差异甲基化基因和途径.
主要方法:
- 对人类大脑组织和纯化脑细胞类型的表观遗传学研究的审查.
- 全球甲基化水平,候选基因和表观基因组范围的关联研究 (EWAS) 的分析.
- 包括最近的元分析和新兴技术的讨论.
主要成果:
- 确定了与阿尔茨海默病相关的关键差异甲基化基因和途径.
- 总结了全球甲基化,候选基因和EWAS方法的研究结果.
- 强调了DNA甲基化在理解AD病变发生过程中的重要性.
结论:
- 基因甲基化是阿尔茨海默病的关键表观遗传因素.
- 结合多原子数据和新技术的进一步研究将促进对AD表观遗传学的理解.
- 研究DNA甲基化为阿尔茨海默氏症的新疗法提供了潜在的治疗策略.
相关概念视频
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Role of Neurotransmitters in Memory
456
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
456
Dementia
97
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
97


